Sleep Apnea Solution author Dylan Petkus, MD, has developed a non-device, behavior-based alternative approach to sleep apnea.

The Food and Drug Administration (FDA) has approved Breztri Aerosphere ® (budesonide/glycopyrrolate/formoterol fumarate; BGF) for the maintenance treatment of asthma in adult and ...

In cystic fibrosis, ETI significantly reduced daily cough frequency and increased physical activity levels in patients aged 12 and older.

Anxiety and depression are prevalent in patients with IPF and are linked to increased breathlessness and lower energy levels.

The FDA is moving to speed drug development and review by launching real-time clinical trials, which could mean more options for patients.

The FDA has accepted the NDA for zipalertinib to treat adult patients with locally advanced or metastatic EGFR exon 20 insertion-mutated NSCLC.

The updated guideline also strongly recommends RSV vaccination in adults and adolescents with compromised immunity. RSV ...

Oncologists are leveraging TikTok to provide evidence-based cancer education, breaking down complex clinical topics for ...

Race-based medicine continues to negatively impact Black patient populations, advocated Joel Bervell, MD, at RPA 2026.

Cannabis use may impact glycemic control by impairing self-management behaviors and delaying gastric emptying among patients ...

There are differences between familial and idiopathic pulmonary fibrosis in terms of cluster of differentiation 20 and CD3 expression.

CFTR modulators, especially triple therapy, significantly improve sinonasal inflammation and nasal polyp size in patients with cystic fibrosis.